Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Liabilities and Shareholders Equity: 2020-2024

Historic Liabilities and Shareholders Equity for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $690.6 million.

  • Cellebrite DI's Liabilities and Shareholders Equity rose 32.59% to $834.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 34.45%. This contributed to the annual value of $690.6 million for FY2024, which is 29.59% up from last year.
  • Latest data reveals that Cellebrite DI reported Liabilities and Shareholders Equity of $690.6 million as of FY2024, which was up 29.59% from $532.9 million recorded in FY2023.
  • Cellebrite DI's Liabilities and Shareholders Equity's 5-year high stood at $690.6 million during FY2024, with a 5-year trough of $339.8 million in FY2021.
  • Over the past 3 years, Cellebrite DI's median Liabilities and Shareholders Equity value was $532.9 million (recorded in 2023), while the average stood at $542.2 million.
  • As far as peak fluctuations go, Cellebrite DI's Liabilities and Shareholders Equity decreased by 6.75% in 2021, and later skyrocketed by 32.13% in 2023.
  • Yearly analysis of 5 years shows Cellebrite DI's Liabilities and Shareholders Equity stood at $364.4 million in 2020, then decreased by 6.75% to $339.8 million in 2021, then climbed by 18.69% to $403.3 million in 2022, then spiked by 32.13% to $532.9 million in 2023, then grew by 29.59% to $690.6 million in 2024.